Journal of Mosquito Research, 2024, Vol.14, No.5, 264-275 http://emtoscipublisher.com/index.php/jmr 275 Petrov A., Plekhanova T.M., Sidorova O.N., Borisevich S., and Makhlay A., 2015, The vaccines based on the replicon of the Venezuelan equine encephalomyelitis virus against viral hemorrhagic fevers, Voprosy Virusologii, 60(3): 14-18. Rojas A., Hachey W., Kaur G., Korejwo J., and Muhammad R., 2023, Enhanced safety surveillance of STAMARIL® yellow fever vaccine provided under the expanded access investigational new drug program in the USA, Journal of Travel Medicine, 30(7): taad037. https://doi.org/10.1093/jtm/taad037 Shou C.J., and Cai X.P., 2024, Analysis of animal vaccine classification and current status, Journal of Vaccine Research, 14(1): 10-16. https://doi.org/10.5376/jvr.2024.14.0002 Silva J.V.J., Lopes T.R.R., Oliveira-Filho E.F., Durães-Carvalho R., and Gil L., 2018, Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses, Acta Tropica, 182: 257-263. https://doi.org/10.1016/j.actatropica.2018.03.009 Tottey S., Shoji Y., Jones R.M., Chichester J., Green B., Musiychuk K., and Yusibov V., 2017, Plant-produced subunit vaccine candidates against yellow fever induce virus neutralizing antibodies and confer protection against viral challenge in animal models, The American Journal of Tropical Medicine and Hygiene, 98(2): 420-431. https://doi.org/10.4269/ajtmh.16-0293 Umar K., Anka A., Abdullahi I., Emeribe A., Babayo A., Adekola H., Danmusa U., and Uzairue L., 2020, The interplay between epigenetics, vector competence and vaccine immunodynamics as a possible explanation for recent yellow fever resurgence in Nigeria, African Journal of Health Sciences, 32: 38-52. Vasconcelos P.F., and Barrett A., 2019, Are booster doses of yellow fever vaccine needed? The Lancet, Infectious Diseases, 19(12): 1275-1276. https://doi.org/10.1016/S1473-3099(19)30411-6 Wang H., Guo Y., He M., Liu Z., Ye Q., Huang X., Deng Y., Li X., and Qin C., 2022, Development of a bicistronic yellow fever live attenuated vaccine with reduced neurovirulence and viscerotropism, Microbiology Spectrum, 10(5): e02246-22. https://doi.org/10.1128/spectrum.02246-22 Yang L.B., 2024, Genome driven personalized drug therapy, International Journal of Clinical Case Reports, 14(1): 40-47. https://doi.org/10.5376/ijccr.2024.14.0005
RkJQdWJsaXNoZXIy MjQ4ODYzNA==